HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Petition To Prevent Generic Premarin: When Is A Horse Not A Horse?

Executive Summary

Barr is bracing for Wyeth to renew its citizen petition campaign to block generic Premarin (conjugated estrogens)made from pregnant horses' urine
Advertisement

Related Content

Wyeth Premarin Petition Withdrawn; Firm Hints At Future Action
Wyeth Premarin Petition Withdrawn; Firm Hints At Future Action
Prempro, Premarin Not Indicated For Coronary Heart Disease – Revised Label
Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review
Barr Generic Premarin Development Plan Includes Exclusive Supply Deal
WYETH-AYERST COMMITS TO CHARACTERIZATION OF PREMARIN, FDA SAYS; GENERIC CONJUGATED ESTROGENS MAY NOT BE APPROVED UNTIL PREMARIN IS CHARACTERIZED
WYETH-AYERST COMMITS TO CHARACTERIZATION OF PREMARIN, FDA SAYS; GENERIC CONJUGATED ESTROGENS MAY NOT BE APPROVED UNTIL PREMARIN IS CHARACTERIZED
Advertisement
UsernamePublicRestriction

Register

PS040525

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel